Nautilus Biotechnology, Inc. (NAUT) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
NAUT currently has 127M outstanding shares. with moderate dilution risk from 61M authorized shares representing 48.1% potential dilution. The company has minimally diluted shareholders by 1.07% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 28, 2026 |
10-Q filing | 126.6M shares outstanding |
130M | 61M |
| Oct 28, 2025 |
10-Q filing | 126.3M shares outstanding |
130M | 61M |
| Jul 31, 2025 |
10-Q filing | 126.2M shares outstanding |
130M | 61M |
| Apr 29, 2025 |
10-Q filing | 126.1M shares outstanding |
130M | 61M |
| Feb 27, 2025 |
10-K filing | 125.4M shares outstanding |
130M | 61M |
| Oct 29, 2024 |
10-Q filing | 125.5M shares outstanding |
130M | 61M |
| Jul 30, 2024 |
10-Q filing | 125.3M shares outstanding |
130M | 61M |
| Apr 30, 2024 |
10-Q filing | 125.1M shares outstanding |
130M | 61M |
| Feb 28, 2024 |
S-3 filing: S-3 filing for an at-the-market offering of common stock with an aggregate offering price of up to $125,000,000. |
130M | 61M |
| Feb 28, 2024 |
10-K filing | 124.9M shares outstanding |
120M | 61M |
| Oct 31, 2023 |
10-Q filing | 124.9M shares outstanding |
120M | 18M |
| Aug 02, 2023 |
10-Q filing | 124.6M shares outstanding |
120M | 18M |
| May 02, 2023 |
10-Q filing | 124.6M shares outstanding |
120M | 18M |
| Feb 23, 2023 |
10-K filing | 124.6M shares outstanding |
120M | 18M |
| Nov 01, 2022 |
10-Q filing | 124.7M shares outstanding |
120M | 18M |
| Aug 02, 2022 |
POS AM filing: This POS AM filing registers an aggregate of 88,738,387 shares of common stock for resale by selling securityholders. The company will not receive any proceeds from the sale of these shares. |
120M | 18M |
| Aug 02, 2022 |
10-Q filing | 124.5M shares outstanding |
120M | 18M |
| May 03, 2022 |
10-Q filing | 124.4M shares outstanding |
120M | 18M |
| Feb 24, 2022 |
10-K filing | 124.4M shares outstanding |
120M | 18M |
| Feb 24, 2022 |
POS AM filing: This prospectus relates to the resale of 4,286,500 shares of common stock, the resale of 69,655,827 shares of Common Stock, the resale of 20,000,000 shares of common stock issued in the PIPE Financing, and the issuance by us and resale of 1,702,729 shares of Common Stock reserved for issuance upon the exercise of certain outstanding options to purchase Common Stock. |
120M | 18M |
| Nov 02, 2021 |
10-Q filing | 124.1M shares outstanding |
120M | 110M |
| Aug 10, 2021 |
10-Q filing | 124.1M shares outstanding |
120M | 110M |
| Jul 22, 2021 |
S-1 filing: This S-1 filing registers the resale of common stock issued in connection with a Domestication, Business Combination, PIPE Financing, and shares issuable upon exercise of certain outstanding options. |
890M | 110M |
| May 13, 2021 |
10-Q filing | 3.7M shares outstanding |
3.7M | 18M |
| Mar 30, 2021 |
10-K filing | 3.7M shares outstanding |
3.7M | 18M |
| Nov 13, 2020 |
10-Q filing | 3.7M shares outstanding |
3.7M | 18M |
| Sep 18, 2020 |
10-Q filing | 3.7M shares outstanding |
3.7M | 18M |
| Aug 12, 2020 |
8-K filing: ARYA Sciences Acquisition Corp III consummated its IPO of 14,950,000 Class A ordinary shares at $10.00 per share, generating gross proceeds of $149,500,000. It also completed a private placement of 499,000 Class A ordinary shares to ARYA Sciences Holdings III at $10.00 per share, generating proceeds of $4,990,000. ($154.49M proceeds) |
3.6M | 18M |
| Jul 30, 2020 |
S-1/A filing: This S-1/A filing describes an offering of Class A ordinary shares, with an underwriter option for additional shares, as well as details regarding Sponsor Shares and Founder Shares transactions. It outlines agreements related to the offering, including underwriting, trust, subscription, and registration rights agreements. |
3.6M | 18M |
| Jul 21, 2020 |
S-1 filing: ARYA Sciences Acquisition Corp III is offering Class A ordinary shares in an initial public offering and private placements. |
3.6M | 15M |